Madrigal Pharmaceuticals, Inc. (MDGL)
571.40
+18.93
(+3.43%)
USD |
NASDAQ |
Dec 11, 16:00
565.01
-6.39
(-1.12%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash from Investing (Quarterly): -207.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Amicus Therapeutics, Inc. | -1.299M |
| Insmed, Inc. | -762.23M |
| Ionis Pharmaceuticals, Inc. | 91.34M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 79.85M |
| Cash from Financing (Quarterly) | 236.65M |
| Free Cash Flow | -164.63M |
| Free Cash Flow Per Share (Quarterly) | 3.380 |
| Free Cash Flow to Equity (Quarterly) | -146.46M |
| Free Cash Flow to Firm (Quarterly) | 83.44M |
| Free Cash Flow Yield | -1.30% |